The haemodynamic effects of oxytocin on the pulmonary and systemic circulation were studied in six awake, pregnant (> 140 days gestation) ewes. Bolus doses of oxytocin 0.2 units/kg and then 0.8 units/kg were administered. A dose of 0.2 units/kg resulted in small but significant increases in mean pulmonary artery pressure (14%, P< 0.05) and pulmonary vascular resistance (24%, P< 0.05. A bolus of 0.8 units/kg resulted in a significant increase in mean arterial pressure (20%, P < 0.05) and systemic vascular resistance (33%, P< 0.05). Acute pulmonary hypertension was then induced with glass bead microemboli (150-200 pm), with an increase in pulmonary artery pressure of 26 mmHg and pulmonary vascular resistance of 448 dyn. s. cm -5. Boluses of oxytocin 0.2 and 0.8 units/kg were then administered. There were no significant changes, except for a 30% increase in systemic vascular resistance at one minute after oxytocin, 0.8 units/kg (P< 0.05).
The effects of oxytocin on the pulmonary vasculature have seldom been investigated. We recently noted an increase in pulmonary vascular resistance (PVR) and mean pulmonary artery pressure (PAP) with the administration of oxytocin in a pregnant woman with primary pulmonary hypertension. 1 Two previous case reports noted an increase in pulmonary artery pressure with administration of oxytocin in women with primary pulmonary hypertension. 2 ,3 Our aim was to investigate the effects of oxytocin on the circulation in late gestation ewes and then to observe the effects of oxytocin after the induction of acute pulmonary hypertension with glass bead micro-emboli.
MATERIALS AND METHODS
Six pregnant ewes at late gestation (> 140 days) were studied. Anaesthesia was induced with intravenous thiopentone (1.0 g) and maintained with nitrous oxide 50% and halothane 0.5 to 1.5% with an inspired oxygen of 50%. A longitudinal neck incision was made and a nonocclusive carotid artery line and two internal jugular catheters (8. §Research Assistant. ··F.R.A.C.P., Senior Research Fellow. Accepted for publication January 3, 1992 Anaesthesia and Intensive Care, Vol. 20, No. 2. May, 1992 were inserted. A small laparotomy incision was made and an intra-uterine catheter inserted. Streptomycin 500 mg and penicillin 600 mg was administered by intramuscular injection and the animal allowed to recover for twenty-four hours. The following day, the ewe was placed in the upright position in a metabolic cart where all measurements were made. A pulmonary artery catheter (Edwards Thermodilution 93A-131H-75) was inserted via one of the internal jugular catheters. The ewe was allowed to settle over 15 minutes and two control measurements were made over the next 30 minutes. PAP, mean arterial pressure (MAP), right atrial pressure (RAP) and intra-uterine pressure (IUP) were measured continuously with Hewlett Packard transducers (1280 C), carrier amplifier (8805 B) and a Neotrace 8 channel thermal recorder. The transducers were zeroed at right atrial level. Cardiac output (CO) was measured using the thermodilution method with an Edward's Com I Computer and room temperature injectate (10 ml 5% dextrose, temperature differential greater than 12° C). A minimum of three measurements were made and then averaged. Arterial blood gases (ABG's) were measured on a Coming 168 blood gas analyser. Pulmonary artery wedge pressure (P A WP) was measured intermittently and confirmed by pulmonary wedge pressure wave form, and pulmonary artery diastolic pressure (PADP) was always greater than Measurements of CO, ABGs and P A WP were made at 1, 10,40 and 55 minutes after injection. A period of one hour was allowed between oxytocin boluses to allow measurements to return to baseline. Acid washed glass beads (Sigma, 150-200 )lm) were then administered in 5 g aliquots until the PAP was greater than 30 mmHg and cardiac output reduced by 30% below control measurements. A ten-minute stabilisation period was then allowed and further boluses of 0. 
Single factor factorial ANOVA (Statview, SE. Abacus Concepts, California) was used to test any differences between control measurements and post injection measurements at 1, 10 and 40 minutes of physiological variables. Any significant differences between these groups were further analysed by paired Student's t test with Bonferroni correction. In all statistical tests, P < 0.05 was considered significant. Tables 1, 2 at ten minutes, P < 0.05) and SVR (33% at one minute and 25% at ten minutes, P < 0.05) ( Figure   2 ). PAP, PVR and ABGs were not significantly affected.
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Glass bead micro-embolisation (mean 25 g) resulted in a significant increase in PAP (26 mmHg, 129.9%, P< 0.05), PVR(448 dyn. sec. cm -5,546% P < 0.05), and significant decrease in cardiac output (3.8 l/min, 43.5% P< 0.05) and P0 2 (47.3 mmHg, 44.8%, P< 0.05).
After glass bead administration there were no significant changes with administration of oxytocin except for a significant increase in SVR at one minute (30.5%, P < 0.05) after oxytocin 0.8 units/ kg. Oxytocin 0.2 and 0.8 units/kg resulted in a small but significant increase in IUP (7.2 mmHg, P<0.05).
DISCUSSION
In previous human reports adverse responses to oxytocin have been noted with increased P Ap2.3 and when it was measured, increased PVR.l.4 This has been reported in women with primary pulmonary hypertension l . 3 and in a study of male patients with tuberculosis or bronchiectasis of varying severity.4 In this study, four out of fifteen patients had significant increases in PAP (5 mmHg) and PVR (20-40%) in response to ten to fifteen units of oxytocin infused over thirty minutes. 4 Oxytocin may exert these effects by direct actions on the pulmonary vasculature or by central effects with consequent neurally or humorally mediated pulmonary vasoconstriction. This central action could be due to direct action on the central nervous system, perception of painful uterine contractions or a baroreceptor mediated response. In our model, 0.2 units/kg of oxytocin resulted in small, statistically significant but clinically insignificant, increases in PAP and PVR. Interestingly, 0.2 units/kg of oxytocin produced no circulatory changes after pulmonary hypertension had been induced. Perhaps pulmonary vasoconstriction was already maximal. IUP only increased an average of 7.2 mmHg with oxytocin and there was no tachycardia associated with this, excluding painful uterine contractions as a cause of circulatory changes. The uterus of the non-labouring ewe is relatively insensitive to oxytocin. 5 There was, unexpectedly, a significant increase in MAP and SVR with the administration of oxytocin 0.8 units/ kg. This had not been previously reported in sheep. 5 The effects of oxytocin are species variable and hypertensive responses have been noted in rats, rabbits, guinea pigs and possums due to peripheral vasoconstriction. 6 The mechanism for this response has not been elucidated. After pulmonary hypertension was induced, the effects of oxytocin 0.8 units/kg on the systemic circulation were much reduced with only a rise in SVR at one minute (30.5%, P < 0.05).
Glass bead micro-emboli induce pulmonary hypertension via a number of mechanisms; mechanical obstruction, intravascular thrombosis and vasoconstriction via neural or humoral factors. 7 • 10 Mechanical obstruction due to medial hypertrophy and intimal proliferation occurs in primary pulmonary hypertension. This acute model differs in many respects from primary pulmonary hypertension but we thought it valuable to evaluate the effects of oxytocin in the acute setting before developing a chronic model.
Pulmonary vascular responses to oxytocin have not been measured in healthy pregnant women. An intravenous bolus dose of five to ten units of oxytocin results in systemic vasodilation, hypotension and a secondary baroreceptor response with tachycardia and increased cardiac output. 11 -13 This response is short-lived (five to ten minutes) due to the rapid metabolism of oxytocin. This hypotensive action has been noted in dogs in one study14 but in other animal studies the response has been variable. 6 Measurement of PAP, CO and subsequently calculated PVR cannot be justified in healthy pregnant women. Because of these difficulties, the further investigation of oxytocin and the pulmonary vasculature may await the development of an accurate noninvasive measure of pulmonary artery pressure and left atrial pressure.
